Lilliam Ambroggio1,2,3, Helena Herman4, Emily Fain3,5, Guixia Huang2, Todd A Florin3,5. 1. Divisions of Hospital Medicine, lilliam.ambroggio@cchmc.org. 2. Biostatistics and Epidemiology, and. 3. Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; and. 4. Downstate College of Medicine, State University of New York, New York City, New York. 5. Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Abstract
BACKGROUND: Children discharged from the emergency department (ED) with community-acquired pneumonia (CAP) revisit for several reasons, including disease progression or treatment failure. Understanding factors associated with revisits may assist clinicians in preventing subsequent visits. METHODS: Children aged 3 months to 18 years with an International Classification of Diseases, Ninth Revision diagnosis of CAP between December 1, 2009 and April 31, 2013 were eligible. The primary outcome was a CAP-related ED visit or hospitalization within 30 days of the index visit. The secondary outcome was a CAP-related ED visit within 48 hours of discharge from the index visit. The association between clinical variables and an ED revisit for children with CAP was assessed by using multivariable logistic regression models. RESULTS: Of the 3304 index ED visits by patients with CAP, 148 (4.5%) revisited the ED. Children with complex chronic conditions (CCCs) were 2.23 times as likely to revisit the ED as those without a CCC (95% confidence interval: 1.29-3.86). Children admitted and those who received aminopenicillins at the index visit were less likely (63% and 49%, respectively) to revisit the ED (95% confidence interval: 0.24-0.56 and 0.30-0.85, respectively). CONCLUSIONS: Although children with CAP have a relatively low revisit rate to the ED, patients who received aminopenicillins at their index visit were statistically less likely to revisit when adjusting for markers of severity (eg, age, CCCs, and disposition at index visit). Clinical factors alone, however, may not be the only indicators of revisits, and additional factors may need to be considered in future studies.
BACKGROUND:Children discharged from the emergency department (ED) with community-acquired pneumonia (CAP) revisit for several reasons, including disease progression or treatment failure. Understanding factors associated with revisits may assist clinicians in preventing subsequent visits. METHODS:Children aged 3 months to 18 years with an International Classification of Diseases, Ninth Revision diagnosis of CAP between December 1, 2009 and April 31, 2013 were eligible. The primary outcome was a CAP-related ED visit or hospitalization within 30 days of the index visit. The secondary outcome was a CAP-related ED visit within 48 hours of discharge from the index visit. The association between clinical variables and an ED revisit for children with CAP was assessed by using multivariable logistic regression models. RESULTS: Of the 3304 index ED visits by patients with CAP, 148 (4.5%) revisited the ED. Children with complex chronic conditions (CCCs) were 2.23 times as likely to revisit the ED as those without a CCC (95% confidence interval: 1.29-3.86). Children admitted and those who received aminopenicillins at the index visit were less likely (63% and 49%, respectively) to revisit the ED (95% confidence interval: 0.24-0.56 and 0.30-0.85, respectively). CONCLUSIONS: Although children with CAP have a relatively low revisit rate to the ED, patients who received aminopenicillins at their index visit were statistically less likely to revisit when adjusting for markers of severity (eg, age, CCCs, and disposition at index visit). Clinical factors alone, however, may not be the only indicators of revisits, and additional factors may need to be considered in future studies.
Authors: Mark I Neuman; Matthew Hall; James C Gay; Anne J Blaschke; Derek J Williams; Kavita Parikh; Adam L Hersh; Thomas V Brogan; Jeffrey S Gerber; Carlos G Grijalva; Samir S Shah Journal: Pediatrics Date: 2014-07 Impact factor: 7.124
Authors: John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson Journal: Clin Infect Dis Date: 2011-08-31 Impact factor: 9.079
Authors: Ayobami T Akenroye; Cary W Thurm; Mark I Neuman; Elizabeth R Alpern; Geetanjali Srivastava; Sandra P Spencer; Harold K Simon; Javier Tejedor-Sojo; Craig H Gosdin; Elizabeth Brennan; Laura M Gottlieb; James C Gay; Richard E McClead; Samir S Shah; Anne M Stack Journal: J Hosp Med Date: 2014-10-23 Impact factor: 2.960
Authors: Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah Journal: Pediatr Infect Dis J Date: 2012-10 Impact factor: 2.129
Authors: Derek J Williams; Samir S Shah; Angela Myers; Matthew Hall; Katherine Auger; Mary Ann Queen; Karen E Jerardi; Lauren McClain; Catherine Wiggleton; Joel S Tieder Journal: JAMA Pediatr Date: 2013-09 Impact factor: 16.193
Authors: Peter S Hussey; Melony E Sorbero; Ateev Mehrotra; Hangsheng Liu; Cheryl L Damberg Journal: Health Aff (Millwood) Date: 2009 Sep-Oct Impact factor: 6.301
Authors: Derek J Williams; Matthew Hall; Samir S Shah; Kavita Parikh; Amy Tyler; Mark I Neuman; Adam L Hersh; Thomas V Brogan; Anne J Blaschke; Carlos G Grijalva Journal: Pediatrics Date: 2013-10-28 Impact factor: 7.124
Authors: Matthew J Lipshaw; Michelle Eckerle; Todd A Florin; Eric J Crotty; Jessi Lipscomb; Judd Jacobs; Mantosh S Rattan; Richard M Ruddy; Samir S Shah; Lilliam Ambroggio Journal: Pediatrics Date: 2020-03-16 Impact factor: 7.124